Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report

BACKGROUND: The incidence of gemcitabine-induced hemolytic uremic syndrome has already been described in adults. Several approaches have been employed in the treatment of gemcitabine-induced hemolytic uremic syndrome with different outcomes. One of the most promising agents is eculizumab, which is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Facchini, Ludovica, Lucchesi, Maurizio, Stival, Alessia, Roperto, Rosa Maria, Melosi, Francesca, Materassi, Marco, Farina, Silvia, Tintori, Veronica, de Martino, Maurizio, Sardi, Iacopo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530476/
https://www.ncbi.nlm.nih.gov/pubmed/28747219
http://dx.doi.org/10.1186/s13256-017-1373-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530476/
https://www.ncbi.nlm.nih.gov/pubmed/28747219
http://dx.doi.org/10.1186/s13256-017-1373-5

Ejemplares similares